Tyra Biosciences, Inc. TYRA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s total equity?
- Tyra Biosciences, Inc. (TYRA) reported total equity of $387.58M in Q1 2026.
- How has Tyra Biosciences, Inc.'s total equity changed year-over-year?
- Tyra Biosciences, Inc.'s total equity increased by 19.8% year-over-year, from $323.53M to $387.58M.
- What is the long-term trend for Tyra Biosciences, Inc.'s total equity?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s total equity has grown at a 80.2% compound annual growth rate (CAGR), from -$13.64M to $259.18M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.